Literature DB >> 12393502

Translocation t(11;14)(q13;q32) is the hallmark of IgM, IgE, and nonsecretory multiple myeloma variants.

Hervé Avet-Loiseau1, Richard Garand, Laurence Lodé, Jean-Luc Harousseau, Régis Bataille.   

Abstract

In an attempt to address the issue of cytogenetic features of multiple myeloma (MM) variants, we have analyzed a series of 8 IgM, 9 IgD, 2 IgE, and 14 nonsecretory (NS) MM cases using fluorescence in situ hybridization. A very high incidence (83%) of t(11;14)(q13;q32) was detected in the IgM (7 of 8), IgE (2 of 2), and NS (11 of 14) MM cases, but not in the IgD cases (2 of 9). Of note, no t(4;14) was observed in this cohort of patients. This increased incidence of t(11;14) was associated with 2 dominant features in these variants, namely, a "lymphoplasmacytic" presentation mainly in IgM MM and a lower secreting capacity in the others, 2 features previously associated with t(11;14). Of major interest, t(11;14) was never observed in Waldenström macroglobulinemia or in IgG/IgA "lymphoplasmacytic" lymphomas. Thus, for unknown reasons, t(11;14) is the hallmark of IgM, IgE, and NS MM, (but not IgD MM), with a 5-fold increase of its incidence compared to that of IgG and IgA MM.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12393502     DOI: 10.1182/blood-2002-08-2436

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  39 in total

1.  Clinical implications of t(11;14)(q13;q32), t(4;14)(p16.3;q32), and -17p13 in myeloma patients treated with high-dose therapy.

Authors:  Morie A Gertz; Martha Q Lacy; Angela Dispenzieri; Philip R Greipp; Mark R Litzow; Kimberly J Henderson; Scott A Van Wier; Greg J Ahmann; Rafael Fonseca
Journal:  Blood       Date:  2005-06-23       Impact factor: 22.113

2.  Natural history of t(11;14) multiple myeloma.

Authors:  A Lakshman; M Alhaj Moustafa; S V Rajkumar; A Dispenzieri; M A Gertz; F K Buadi; M Q Lacy; D Dingli; A L Fonder; S R Hayman; M A Hobbs; W I Gonsalves; Y L Hwa; P Kapoor; N Leung; R S Go; Y Lin; T V Kourelis; J A Lust; S J Russell; S R Zeldenrust; R A Kyle; S K Kumar
Journal:  Leukemia       Date:  2017-06-27       Impact factor: 11.528

3.  Secretory status of monoclonal immunoglobulin is related to the outcome of patients with myeloma: a retrospective study.

Authors:  Xiao-Qi Qin; Gang An; Zeng-Jun Li; Lan-Ting Liu; Yan Xu; Lin-Hua Yang; Yan-Ping Ma; Shu-Hui Deng; Wei-Wei Sui; Yu Qin; Xiao-Yan Feng; Mei-Rong Zang; Wen-Juan Yang; Yan-Ru Zhang; Shu-Hua Yi; Ting-Yu Wang; Rui Lv; De-Hui Zou; Yao-Zhong Zhao; Lu-Gui Qiu
Journal:  Blood Adv       Date:  2019-03-12

4.  PAX5-positive plasma cell myeloma with t(9;14;11)(p13;q32;q13), a novel complex variant translocation of t(11;14)(q13;q32) and t(9;14)(p13;q32).

Authors:  Kazuyuki Sato; Hirotaka Sakai; Masayuki Kato; Yuji Nishio; Yuka Tsuruoka; Yu Uemura; Satoshi Yokoi; Tasuku Saito; Manabu Matsunawa; Yoshinori Suzuki; Yasushi Isobe; Yasuyuki Inoue; Masatomo Takahashi; Ikuo Miura
Journal:  Int J Hematol       Date:  2015-01-30       Impact factor: 2.490

5.  Gene-expression profiling of Waldenstrom macroglobulinemia reveals a phenotype more similar to chronic lymphocytic leukemia than multiple myeloma.

Authors:  Wee J Chng; Roelandt F Schop; Tammy Price-Troska; Irene Ghobrial; Neil Kay; Diane F Jelinek; Morie A Gertz; Angela Dispenzieri; Martha Lacy; Robert A Kyle; Philip R Greipp; Renee C Tschumper; Rafael Fonseca; Peter Leif Bergsagel
Journal:  Blood       Date:  2006-06-27       Impact factor: 22.113

Review 6.  Monoclonal IgM Gammopathy and Waldenström's Macroglobulinemia.

Authors:  Alexander Grunenberg; Christian Buske
Journal:  Dtsch Arztebl Int       Date:  2017-11-03       Impact factor: 5.594

Review 7.  Acute renal failure due to cast nephropathy in nonsecretory myeloma: a case report and review of the literature.

Authors:  S Karthik Kumar; Preet M Sohal; Harbir S Kohli; Kamal Sud; Krishan L Gupta; Kusum Joshi; Vinay Sakhuja; Vivekanand Jha
Journal:  Int Urol Nephrol       Date:  2005       Impact factor: 2.370

Review 8.  Pathogenesis of monoclonal gammopathy of undetermined significance and progression to multiple myeloma.

Authors:  Adriana Zingone; W Michael Kuehl
Journal:  Semin Hematol       Date:  2011-01       Impact factor: 3.851

9.  IgM multiple myeloma with an extremely rare non-aggressive presentation: A case report.

Authors:  Thomas Greuter; Martin Browne; Corina Dommann-Scherrer; Daniel Binder; Christoph Renner; Ursula Kapp
Journal:  Oncol Lett       Date:  2016-08-17       Impact factor: 2.967

10.  Prozone effect of serum IgE levels in a case of plasma cell leukemia.

Authors:  Giampaolo Talamo; William Castellani; Nathan G Dolloff
Journal:  J Hematol Oncol       Date:  2010-09-10       Impact factor: 17.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.